Logo image
Back
Degrees of dysplasia and the use of cidofovir in patients with recurrent respiratory papillomatosis
Journal article   Peer reviewed

Degrees of dysplasia and the use of cidofovir in patients with recurrent respiratory papillomatosis

Hina T Gupta, Robert A Robinson, Ryan C Murray, Lucy H Karnell, Richard J H Smith and Henry T Hoffman
The Laryngoscope, Vol.120(4), pp.698-702
04/2010
DOI: 10.1002/lary.20785
PMID: 20205173

View Online

Abstract

Recurrent respiratory papillomatosis (RRP) is a benign disease characterized by recurrent lesions in the airway. The prevalence and degree of dysplasia that is present in the natural course of RRP is not well established. Adjuvant therapies, such as cidofovir, have been tried with the goal of decreasing the interval between repeat surgical treatments, the mainstay of therapy. Although, the off-label use of cidofovir to treat RRP has been common, there have been concerns regarding carcinogenic transformation following the use of cidofovir. This study aims to explore the association between increasing degree of papilloma dysplasia and the use of cidofovir in the context of the natural progression of dysplasia in RRP. Retrospective case series. Demographic data and surgical history were obtained through chart reviews for this retrospective case series of 13 patients with RRP who had histopathologic biopsies done before and after exposure to cidofovir. Pathologic data collected over 10 years from serial excisions at the University of Iowa Hospitals were reviewed by a single pathologist, and the highest degree of dysplasia was noted per excision time. Of the 176 specimens collected in these 13 patients with serial papilloma biopsies, 5.7% had no dysplasia, 57.4% had mild dysplasia (grade 1), 28.4% had moderate dysplasia (grade 2), and 8.5% had severe dysplasia (grade 3). A comparison of each patient's multiple biopsies across time suggested that the dysplastic grade was worse in two patients, better in four patients, and virtually unchanged in seven patients. There was no clear-cut pattern between the use of cidofovir and the degree of dysplasia over time. These results strongly suggest that intralesional cidofovir therapy does not correlate with worsening dysplastic progression. Dysplasia is relatively common in the setting of RRP; however, the prognostic significance of this finding is unknown. Additional research is needed to delineate the natural progression of dysplasia and its clinical significance in RRP, as well as the efficacy of cidofovir.
 Severity of Illness Index Cytosine - analogs & derivatives Respiratory Tract Neoplasms - drug therapy Follow-Up Studies Organophosphonates - therapeutic use Humans Middle Aged Neoplasm Recurrence, Local - drug therapy Cytosine - administration & dosage Male Treatment Outcome Disease Progression Neoplasm Recurrence, Local - pathology Respiratory Mucosa - pathology Organophosphonates - administration & dosage Time Factors Biopsy Adult Female Papilloma Respiratory Tract Neoplasms - pathology Aged Cytosine - therapeutic use Retrospective Studies

Details

Metrics

26 Record Views
17 Times Cited - Web of Science
Logo image